Sarepta Therapeutics | SRPT - Market Capitalization


Sarepta Therapeutics reported $1.77B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Agios Pharmaceuticals USD 1.6B 16M Feb/2026
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
BioCryst Pharmaceuticals USD 1.23B 115M Dec/2023
Biogen USD 27.01B 1.19B Feb/2026
BioMarin Pharmaceutical USD 12.21B 1.81B Feb/2026
Capricor Therapeutics USD 207M 227M Jun/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 1.01T 3.37B Feb/2026
Esperion Therapeutics USD 340M 235M Dec/2023
Gilead Sciences USD 183.59B 31.31B Feb/2026
Incyte USD 22.7B 3.31B Feb/2026
Insmed USD 23.91B 13.21B Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Moderna USD 16.5B 6.41B Feb/2026
Nektar Therapeutics USD 113M 4M Sep/2023
Neurocrine Biosciences USD 13.68B 465M Feb/2026
Novavax USD 684M 43M Sep/2023
Pfizer USD 152.89B 11.32B Feb/2026
PTC Therapeutics USD 5.36B 744M Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Tectonic Therapeutic USD 294M 77M Sep/2025
Ultragenyx Pharmaceutical USD 1.94B 284M Feb/2026
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026